# Birth Control Hormones: Conventional WWTP Removal Rates > Activated sludge outperforms lagoons and filters for steroidal estrogens, but EE2 removal is incomplete and variable—effluent residuals drive ecological exposure. *Published 2026-07-10 · By Elena Voss* In short Conventional WWTPs **partially** remove contraceptive estrogens: activated sludge often ~**70% EE2 average** in global reviews, with wide scatter. **Effluent residuals** drive ecology—not zero-sum human panic. Birth-control hormones do not vanish at the plant gate. Process type, temperature, and solids retention time decide how much ethinylestradiol leaves with the effluent. *This article is informational and editorial only. It is not medical advice, diagnosis, or a treatment plan. Numbers and literature ranges cited here are not personal prescriptions. Consult a qualified clinician before changing medications, supplements, diet, equipment, or management of a diagnosed condition. Seek urgent care for emergencies.* ## What average removals appear by process? Tang et al. 2021 summarized EE2 averages rising from primary to activated sludge. Negative removals in datasets reflect deconjugation and sampling artifacts. Secondary treatment assumptions in U.S. modeling have used roughly ~80% EE2 removal in some PECs—still not 100%. ## How do natural estrogens compare? 17β-estradiol is often highly removed (~85–99% in many comparisons). Estrone can be more variable and can rise when E2 converts. Compound-specific behavior forbids one “estrogen %” slogan. Key reference points ProcessApprox. avg EE2 removal (Tang 2021)Note Primary~47.5%Lowest Bio filter~55%Variable Lagoon~59%Climate sensitive Activated sludge~71.5%Often best conventional ## What operational factors break performance? Short SRT, cold temperatures, hydraulic overloading, and high industrial fractions. Trickling filters and lagoons often underperform optimized activated sludge. Advanced oxidation and ozone/GAC are upgrade paths beyond conventional secondary. ## How should editors frame risk? Ecological intersex and vitellogenin literature uses effluent and surface-water ng/L bands. Human finished-water intakes require separate dose bridges. Plant engineering upgrades are watershed tools, not proof of human clinical catastrophe. Sources: [Tang et al. 2021 EE2 WWTP review](https://pubmed.ncbi.nlm.nih.gov/33453480/); [Laurenson 2014 drinking-water estrogens](https://pmc.ncbi.nlm.nih.gov/articles/PMC3933577/); [Ziels et al. EE2 SRT](https://pubs.acs.org/doi/10.1021/es405351b). Readers should dual-source primary literature, translate slogans into exposure units and effect sizes, and rank interventions by expected value under uncertainty. Cheap reversible steps often outrank extreme protocols. Opportunity cost is real: hours spent on unvalidated tests are hours not spent on sleep, training, protein adequacy, and primary care. Sex, life stage, comorbidities, medications, and geography change interpretation. Prefer falsifiable claims with named endpoints over multi-disease cure lists. Update beliefs when stronger trials appear rather than freezing identity around a single paper or influencer narrative. Measured curiosity beats both panic and complacency. Further reading should prioritize primary sources and consensus documents over secondary social summaries. When evidence is mixed, state both the signal and the limits in the same paragraph. When evidence is strong, still avoid overclaiming universality across populations. Pattern quality, dose, and adherence dominate most household decisions more than brand seals. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Household decisions should favor reversible experiments with measurable outcomes over identity diets or unvalidated testing cascades. When numbers conflict across agencies, report both the public-health target and the regulatory ceiling, then place personal labs on that ladder explicitly. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Household decisions should favor reversible experiments with measurable outcomes over identity diets or unvalidated testing cascades. When numbers conflict across agencies, report both the public-health target and the regulatory ceiling, then place personal labs on that ladder explicitly. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Household decisions should favor reversible experiments with measurable outcomes over identity diets or unvalidated testing cascades. When numbers conflict across agencies, report both the public-health target and the regulatory ceiling, then place personal labs on that ladder explicitly. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Household decisions should favor reversible experiments with measurable outcomes over identity diets or unvalidated testing cascades. When numbers conflict across agencies, report both the public-health target and the regulatory ceiling, then place personal labs on that ladder explicitly. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Household decisions should favor reversible experiments with measurable outcomes over identity diets or unvalidated testing cascades. When numbers conflict across agencies, report both the public-health target and the regulatory ceiling, then place personal labs on that ladder explicitly. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Household decisions should favor reversible experiments with measurable outcomes over identity diets or unvalidated testing cascades. When numbers conflict across agencies, report both the public-health target and the regulatory ceiling, then place personal labs on that ladder explicitly. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Household decisions should favor reversible experiments with measurable outcomes over identity diets or unvalidated testing cascades. When numbers conflict across agencies, report both the public-health target and the regulatory ceiling, then place personal labs on that ladder explicitly. Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Household decisions should favor reversible experiments with measurable outcomes over identity diets or unvalidated testing cascades. When numbers conflict across agencies, report both the public-health target and the regulatory ceiling, then place personal labs on that ladder explicitly. ## Sources 1. [Tang et al. 2021 EE2 WWTP review](https://pubmed.ncbi.nlm.nih.gov/33453480/) 2. [Laurenson 2014 drinking-water estrogens](https://pmc.ncbi.nlm.nih.gov/articles/PMC3933577/) 3. [Ziels et al. EE2 SRT](https://pubs.acs.org/doi/10.1021/es405351b) --- Source: https://healthcanon.com/environmental-health/birth-control-water-conventional-wwtp-removal Index: https://healthcanon.com/llms.txt · Full text: https://healthcanon.com/llms-full.txt